TX-004HR vaginal estradiol has negligible to very low systemic absorption of estradiol

Lignende værker

• Patient acceptability and satisfaction with a low-dose solubilized vaginal estradiol softgel capsule, TX-004HR
  af: Kingsberg, Sheryl A., et al.
  Udgivet: (2017)
• Consistency of Effect with a Low-Dose, Estradiol Vaginal Capsule (TX-004HR): Evaluating Improvement in Vaginal Physiology and Moderate-to-Severe Dyspareunia in Subgroups of Postmenopausal Women
  af: Constantine, Ginger D., et al.
  Udgivet: (2017)
• SAT-238 Predictors Of Vaginal/Uterine Bleeding With Oral TX-001HR (Estradiol and Progesterone) Capsules Taken For Menopausal Vasomotor Symptoms
  af: Constantine, Ginger, et al.
  Udgivet: (2019)
• Improvement in sleep outcomes with a 17β-estradiol–progesterone oral capsule (TX-001HR) for postmenopausal women
  af: Kagan, Risa, et al.
  Udgivet: (2018)
• 17β-estradiol/progesterone in a single, oral, softgel capsule (TX-001HR) significantly increased the number of vasomotor symptom-free days in the REPLENISH trial
  af: Kaunitz, Andrew M., et al.
  Udgivet: (2020)